nitrosobis(2-oxopropyl)amine has been researched along with sulforaphane in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirose, M; Ishii, Y; Kanki, K; Kitamura, Y; Kuroiwa, Y; Nishikawa, A; Umemura, T | 1 |
| Grandhi, BK; Prabhu, S; Thakkar, A; Wang, J | 1 |
2 other study(ies) available for nitrosobis(2-oxopropyl)amine and sulforaphane
| Article | Year |
|---|---|
Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Carcinogenicity Tests; Carcinogens; Cell Transformation, Neoplastic; Cricetinae; Cyclooxygenase 2; Diet; Injections, Subcutaneous; Isothiocyanates; Male; Membrane Proteins; Mesocricetus; Neoplasms, Experimental; Nitrosamines; Pancreatic Neoplasms; Resveratrol; Stilbenes; Sulfoxides; Thiocyanates | 2006 |
A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspirin; Carcinogens; Cell Line, Tumor; Cricetinae; Curcumin; Disease Models, Animal; Disease Progression; Drug Delivery Systems; Immunohistochemistry; In Situ Nick-End Labeling; Isothiocyanates; Lipids; Male; Mesocricetus; Nanoparticles; Nitrosamines; Pancreatic Neoplasms; Proliferating Cell Nuclear Antigen; Sulfoxides | 2013 |